Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Sapu003 in Advanced mTOR-sensitive Solid Tumors — Stella

Home/Breast Cancer Metastatic/Sapu003 in Advanced mTOR-sensitive Solid Tumors

View on ClinicalTrials.gov

Recruiting

Back to Breast Cancer Metastatic trials

Sapu003 in Advanced mTOR-sensitive Solid Tumors

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Australia

SOCRU, Adelaide

Key details

Phase

Early testing

Sponsor

SAPU NANO (US) LLC

Enrollment target

~27 participants

Started

December 2025

Primary completion

June 2026

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.